XTL Biopharmaceuticals Ltd. (FRA:H2K2)

XTL Biopharmaceuticals Statistics

Total Valuation

FRA:H2K2 has a market cap or net worth of EUR 7.44 million. The enterprise value is 6.47 million.

Market Cap	7.44M
Enterprise Value	6.47M

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+29.23%
Shares Change (QoQ)	+22.96%
Owned by Insiders (%)	48.73%
Owned by Institutions (%)	2.70%
Float	451.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.08
PB Ratio	1.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.53
EV / Sales	14.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.01

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.03.

Current Ratio	0.61
Quick Ratio	0.56
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-77.57

Financial Efficiency

Return on equity (ROE) is -26.83% and return on invested capital (ROIC) is -34.84%.

Return on Equity (ROE)	-26.83%
Return on Assets (ROA)	-24.74%
Return on Invested Capital (ROIC)	-34.84%
Return on Capital Employed (ROCE)	-34.24%
Revenue Per Employee	43,562
Profits Per Employee	-99,198
Employee Count	10
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	-125,567
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-60.43%
50-Day Moving Average	0.93
200-Day Moving Average	1.03
Relative Strength Index (RSI)	36.50
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:H2K2 had revenue of EUR 435,621 and -991,979 in losses. Loss per share was -0.00.

Revenue	435,621
Gross Profit	2,898
Operating Income	-2.10M
Pretax Income	-1.12M
Net Income	-991,979
EBITDA	-1.91M
EBIT	-2.10M
Loss Per Share	-0.00

Balance Sheet

The company has 1.10 million in cash and 133,294 in debt, giving a net cash position of 970,730.

Cash & Cash Equivalents	1.10M
Total Debt	133,294
Net Cash	970,730
Net Cash Per Share	n/a
Equity (Book Value)	5.25M
Book Value Per Share	0.01
Working Capital	-837,435

Cash Flow

In the last 12 months, operating cash flow was -1.56 million and capital expenditures -52,159, giving a free cash flow of -1.61 million.

Operating Cash Flow	-1.56M
Capital Expenditures	-52,159
Free Cash Flow	-1.61M
FCF Per Share	n/a

Margins

Gross margin is 0.67%, with operating and profit margins of -481.60% and -227.72%.

Gross Margin	0.67%
Operating Margin	-481.60%
Pretax Margin	-256.54%
Profit Margin	-227.72%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:H2K2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.23%
Shareholder Yield	-29.23%
Earnings Yield	-13.33%
FCF Yield	-21.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Feb 10, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

FRA:H2K2 has an Altman Z-Score of -23.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.68
Piotroski F-Score	n/a